BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17687271)

  • 1. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.
    Deverka PA; Doksum T; Carlson RJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):427-34. PubMed ID: 17687271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular medicine: how, what, and when?
    Woodcock J
    Clin Pharmacol Ther; 2007 Oct; 82(4):376-8. PubMed ID: 17851578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Our genes are not our destiny: incorporating molecular medicine into clinical practice.
    Genuis SJ
    J Eval Clin Pract; 2008 Feb; 14(1):94-102. PubMed ID: 18211650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care.
    Fishman PA; Hornbrook MC; Meenan RT; Goodman MJ
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):124S-43S. PubMed ID: 15375288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease in the United States: a public policy imperative.
    Rettig RA; Norris K; Nissenson AR
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1902-10. PubMed ID: 18922986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commissioning prison health: opportunities and challenges for creating a new prison public health system in Scotland.
    Mackie P; Morling J
    Public Health; 2009 Jun; 123(6):434-7. PubMed ID: 19539830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing considerations for oral medicine.
    Hart TC; Ferrell RE
    J Dent Educ; 2002 Oct; 66(10):1185-202. PubMed ID: 12449214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.
    Phillips KA; Veenstra DL; Ramsey SD; Van Bebber SL; Sakowski J
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):425-32. PubMed ID: 15298364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
    Cohen JW; Cohen SB; Banthin JS
    Med Care; 2009 Jul; 47(7 Suppl 1):S44-50. PubMed ID: 19536015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a high-value delivery system for health care.
    Teisberg EO; Wallace S
    Semin Thorac Cardiovasc Surg; 2009; 21(1):35-42. PubMed ID: 19632561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of telemedicine in fostering health-care innovations to address problems of access, specialty shortages and changing patient care needs.
    Rheuban KS
    J Telemed Telecare; 2006; 12 Suppl 2():S45-50. PubMed ID: 16989674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.
    Malinowski MJ
    Jurimetrics; 2000; 41(1):23-52. PubMed ID: 15744897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultural competence in the era of evidence-based practice.
    Engebretson J; Mahoney J; Carlson ED
    J Prof Nurs; 2008; 24(3):172-8. PubMed ID: 18504032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician integration and retention in a large IDS: economic implications.
    Lakin JD
    Healthc Financ Manage; 2001 Nov; 55(11):36-9. PubMed ID: 11715379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaiser Permanente's evaluation and management of biotech drugs: assessing, measuring, and affecting use.
    Monroe CD; Potter L; Millares M; Barrueta A; Wagner R
    Health Aff (Millwood); 2006; 25(5):1340-6. PubMed ID: 16966731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for adolescent integrative health care in Canada.
    Francoeur C; Patterson C; Arthur HM; Noesgaard C; Swinton M
    J Holist Nurs; 2006 Sep; 24(3):212-9. PubMed ID: 16880418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postacute rehabilitation research and policy recommendations.
    Clohan DB; Durkin EM; Hammel J; Murray P; Whyte J; Dijkers M; Gans BM; Graves DE; Heinemann AW; Worsowicz G
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1535-41. PubMed ID: 17964901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disruptive nature of personalized medicine technologies: implications for the health care system.
    Carlson RJ
    Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.